Is TransMedics Stock a Buy on the Pullback?
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry. The …
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry. The …
Up more than 30 percent YTD, organ transplant technology company TransMedics (NASDAQ:TMDX) has been a major winner among medical sector stocks in 2023. The …